The Vitamin D Testing Market size is anticipated to be USD 917.55 million in 2023. According to Future Market Insights, the market is projected to expand at a significant CAGR of 8.1% and reach USD 1,999.35 million by 2033.
The demand for vitamin D testing is expected to increase positively by 1.08x between 2023 and 2033. This is due to the growing need to treat disorders like thyroid, osteoporosis, and vitamin D deficiency.
Modern Vitamin D Testing Method Helps with Regular Immune System Check
| Attributes | Details |
|---|---|
| Vitamin D Testing Market CAGR (2023 to 2033) | 8.1% |
| Vitamin D Testing Market Size (2023) | USD 917.55 million |
| Vitamin D Testing Market Size (2033) | USD 1,999.35 million |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
With a CAGR of 11.5% by 2033, the vitamin testing market is projected to expand substantially. The vitamin D testing sector is relatively modest, but it has been expanding quickly, as people are becoming aware of the importance of maintaining optimum vitamin D levels for good health.
| Market Size (2018) | USD 672.33 million |
|---|---|
| Market Size (2022) | USD 848.8 million |
| Market CAGR (2018 to 2022) | 6% |
The accuracy and practicality of vitamin D testing kits have substantially increased owing to technological innovation. These assays are now widely accessible and can precisely determine the body's vitamin D levels from a little sample of blood.
The introduction of immunoassay-based techniques, which can identify both vitamin D2 and D3 forms, is a significant development that has boosted the use of vitamin D testing kits. Also, kits make use of cutting-edge technology, including high-performance liquid chromatography and chemiluminescent immunoassays.
Deficiency of vitamin D is relatively common, which is leading to repetitive testing and monitoring to ensure optimum levels in the patient. The health systems globally are being burdened by this rising amount of testing.
As an illustration, the rate of vitamin D testing went from 119 tests per 1000 people in 2015 to 159 tests per 1000 people in 2019, a 34% increase. In Australia, Medicare costs have increased by 42% as a result of this rise.
With the development of smartphone applications and cloud-based platforms, it has become easy for individuals to monitor their vitamin D levels over time. Individuals can also communicate the results with healthcare specialists with these applications. This has made it possible to provide people who are at risk for vitamin D insufficiency with individualized and efficient care.
The popularity of vitamin D testing has increased due to the expanding mass of research on the role of vitamin D in various therapeutic situations.
The market is expanding since at-home vitamin D testing is being used commonly. For instance, Hologram Sciences introduced its first product in April 2021, a vitamin D-based direct-to-consumer brand with a testing component as a home test device for testing.
In 2022, North America dominated the global market. This is explained by the high level of knowledge of routine screening and the favorable regulatory & reimbursement environment, which facilitates access to testing.
One of the main reasons influencing the vitamin D testing demand in the United States is the high prevalence of insufficiency.
In turn, this is boosting the market growth in this area by increasing the adoption rate of vitamin D diagnostics products.
| China Market CAGR (2018 to 2022) | 14.2% |
|---|---|
| China Market Size (2018) | USD 38.4 million |
| China Market Size (2023) | USD 74.9 million |
The market in China is being fueled by the expansion of the healthcare infrastructure and the increasing market penetration of testing kits in China. Depending on a number of variables, including governmental regulations, technical development, and consumer awareness, demand in China is likely to see new heights.
In 2022, the 25-hydroxy vitamin D test category had the leading market share, and throughout the forecast period, it is anticipated to increase at a significant rate. The 25-hydroxy vitamin D test is the best method for determining vitamin D levels.
Over the projection period, the 1, 25-dihydroxy vitamin D test segment is anticipated to have profitable expansion. Patients with hypercalcemia, vitamin D-dependent rickets, or congenital 1-alpha-hydroxylase deficiency are the only groups of people who can use this test.
With the leading segment share in 2022, the osteoporosis indication category dominated the market. This is due to the rising incidence of osteoporosis linked to vitamin D. In the United States, osteoporosis affected more than 10 million people, in 2020, and it is predicted to affect 14 million persons over 50.
There are 200 million women who have osteoporosis worldwide. Testing is expanding as a result of the rising prevalence. Over the forecast period, the rickets indication segment is anticipated to have profitable expansion. The population's rising rate of rickets as a result of extreme vitamin D deficiency over extended periods of time is blamed for the segment's expansion.
With a market share of 2022, the LC-MS technology category dominated the overall market. Due to the accuracy that LC-MS/MS assays for vitamin-D metabolite analysis provide, they have dominated the market.
The precision of testing Vitamin-D metabolite levels serves as a crucial technique to categorize individuals as deficient, so that a suitable supplement prescription may be given, even though cutting-edge diagnostic alternatives are available.
For instance, the Vitamin D Combi ImmuTube LC-MS/MS Kit developed and produced by Immundiagnostik, Inc. is used to measure 25(OH) in plasma and serum quantitatively.
In 2022, the market share belonged to the adult patients category. Osteoporosis is common in the adult population. To maintain a normal level of vitamin D in the body, it is generally recommended that adults take a supplement daily that has 800 international units (20 micrograms) of vitamin D.
Throughout the projected period, the pediatric patient segment is anticipated to increase at a notable rate. Malnutrition among the population of infants and children in resource-constrained nations is blamed for the segment's expansion.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The vitamin D testing industry expansion is being driven by:
These aspects are also helping the market's expansion internationally, along with rising investments made by leading players in research and development for new testing technologies.
Market participants are concentrating on creating cutting-edge medicines for the management of associated medical disorders. For example, Quest Diagnostics has two testing options that can aid in monitoring at-risk patients, spotting deficits and illnesses, and treating the problem after it has been identified.
Recent Developments:
The market boosted at a CAGR of 6% from 2018 to 2022.
Through 2033, the market is to develop at a CAGR of 8.1%.
By 2033, the market is to have expanded to USD 1,999.35 million.
In 2023, the market is anticipated to reach a worth of USD 917.55 million.
Market expansion is accelerated by the advancement of new testing methodologies.
The 25-hydroxy vitamin D test segment dominates the market.
Explore In-vitro Diagnostics Devices Insights
View Reports
Vitamin D Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
